|
ELAC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5527136788005E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.52828877225875E-13 |
| Normal-vs-Stage2 |
1.61489710492901E-11 |
| Normal-vs-Stage3 |
1.66019999969791E-08 |
| Normal-vs-Stage4 |
3.37189999999321E-06 |
| Stage1-vs-Stage2 |
1.476430E-01 |
| Stage1-vs-Stage3 |
2.605900E-02 |
| Stage1-vs-Stage4 |
1.460100E-02 |
| Stage2-vs-Stage3 |
2.770200E-01 |
| Stage2-vs-Stage4 |
2.116500E-02 |
| Stage3-vs-Stage4 |
3.658400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88418203051333E-15 |
| Normal-vs-AfricanAmerican |
1.56909996107402E-09 |
| Normal-vs-Asian |
2.4666002573781E-10 |
| Caucasian-vs-AfricanAmerican |
6.358600E-01 |
| Caucasian-vs-Asian |
7.107900E-02 |
| AfricanAmerican-vs-Asian |
3.087600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62614366416847E-12 |
| Normal-vs-Female |
6.81169998184572E-09 |
| Male-vs-Female |
3.950400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.18739999446882E-08 |
| Normal-vs-Extreme_Weight |
6.7319483321171E-12 |
| Normal-vs-Obese |
1.39040001734259E-10 |
| Normal-vs-Extreme_Obese |
9.742700E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.148400E-01 |
| Normal_Weight-vs-Obese |
8.372400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.272600E-01 |
| Extreme_Weight-vs-Obese |
8.573600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.930200E-01 |
| Obese-vs-Extreme_Obese |
9.180000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.09710000000008E-05 |
| Normal-vs-Age(41-60Yrs) |
9.66999813556413E-11 |
| Normal-vs-Age(61-80Yrs) |
1.63014046705712E-12 |
| Normal-vs-Age(81-100Yrs) |
5.023800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.801600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.627200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.569400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.647200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.093400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.511200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.30130400583562E-11 |
| Normal-VS-Type2 PRCC |
1.62481139653892E-12 |
| Normal-VS-KIRP CIMP |
1.62447832963153E-12 |
| Normal-VS-Unclassified PRCC |
1.87429999999322E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.86069999999328E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.69753100465186E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
2.165400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.40349999999223E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.271410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.41849999999389E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
2.78070000359065E-09 |
| Normal-vs-N2 |
1.18710041796533E-10 |
| N0-vs-N1 |
3.689400E-01 |
| N0-vs-N2 |
2.630400E-02 |
| N1-vs-N2 |
1.478150E-01 |
|
|
